- Investing Ideas
- /
- Chinese Undervalued Stocks Based On Cash Flows
Chinese Undervalued Stocks Based On Cash Flows
UPDATED May 14, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
197 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
300972 | CN¥27.05 | -6.3% | -32.3% | CN¥4.7b | CN¥28.67 | PB5.4x | E75.9% | 0% | Food, Beverage & Tobacco | ||
300839 | CN¥7.74 | -7.5% | -41.7% | CN¥1.9b | CN¥11.71 | PB1.7x | E45.6% | 0% | Materials | ||
603363 | CN¥4.00 | 15.9% | -58.1% | CN¥3.3b | n/a | PE-0.9x | E125.7% | 0% | Food, Beverage & Tobacco | ||
2024 | CN¥1.49 | -2.0% | -26.6% | CN¥13.6b | CN¥2.10 | PB1.2x | E105.4% | 0% | Retail | ||
803 | CN¥4.26 | -1.8% | -46.4% | CN¥2.0b | n/a | PS1.1x | E138.6% | n/a | Capital Goods | ||
603569 | CN¥9.34 | -1.6% | 1.7% | CN¥5.8b | n/a | PE77.8x | E42.3% | 0.7% | Transportation | ||
603856 | CN¥10.90 | 0.4% | -10.5% | CN¥2.8b | CN¥13.30 | PE17.4x | E23.6% | 1.6% | Capital Goods | ||
300286 | CN¥22.45 | 3.3% | -39.6% | CN¥5.0b | CN¥30.30 | PE23.2x | E26.0% | 1.3% | Capital Goods | ||
300871 | CN¥14.75 | -5.4% | -17.4% | CN¥2.4b | n/a | PS2.4x | E60.4% | 1.8% | Pharmaceuticals & Biotech | ||
2707 | CN¥6.45 | -0.8% | -14.0% | CN¥6.3b | CN¥7.73 | PE64.8x | E33.1% | 0% | Consumer Services | ||
893 | CN¥19.67 | 5.4% | -15.1% | CN¥17.6b | CN¥33.23 | PE18.4x | E38.8% | 0% | Materials | ||
603966 | CN¥8.90 | 9.3% | -18.2% | CN¥3.1b | n/a | PE19.4x | E45.6% | 2.4% | Capital Goods | ||
524 | CN¥9.19 | 0.2% | -9.0% | CN¥6.1b | CN¥10.00 | PE73.1x | E38.8% | 0% | Consumer Services | ||
603707 | CN¥13.59 | 0.7% | -2.0% | CN¥22.5b | CN¥16.32 | PS6x | E71.2% | 0.7% | Pharmaceuticals & Biotech | ||
301358 | CN¥38.41 | 3.3% | -12.6% | CN¥29.3b | n/a | PE19.9x | E30.3% | 1.1% | Capital Goods | ||
688177 | CN¥29.90 | -12.1% | -1.3% | CN¥12.6b | CN¥54.00 | PS17.4x | E107.9% | n/a | Pharmaceuticals & Biotech | ||
688080 | CN¥33.49 | -6.8% | -20.1% | CN¥2.5b | CN¥52.96 | PE24.4x | E33.1% | 0.5% | Tech | ||
603113 | CN¥6.92 | -1.4% | -21.5% | CN¥5.9b | n/a | PE23.3x | E36.0% | 1.4% | Materials | ||
605507 | CN¥18.02 | 1.0% | -20.7% | CN¥10.2b | CN¥24.00 | PE16.2x | E35.2% | 1.7% | Pharmaceuticals & Biotech | ||
688676 | CN¥59.30 | 21.6% | 81.3% | CN¥25.6b | CN¥50.77 | PE51.3x | E35.0% | 0.8% | Capital Goods | ||
682 | CN¥11.25 | 4.5% | 21.9% | CN¥15.7b | CN¥14.91 | PE26.7x | E22.5% | 0.7% | Capital Goods | ||
301168 | CN¥32.50 | -1.1% | -38.7% | CN¥3.9b | CN¥40.00 | PE23.8x | E34.5% | 0.5% | Capital Goods | ||
300589 | CN¥12.47 | 2.9% | -20.0% | CN¥4.7b | n/a | PE89.6x | E50.8% | 0.2% | Capital Goods | ||
2912 | CN¥20.02 | -3.6% | -51.6% | CN¥3.4b | CN¥35.00 | PE200.6x | E84.7% | 1.5% | Tech |